General Comments / Chat, page-9979

Back when I first became a part owner of this company Long Tony's CPACS didn't exist although I think Dr T had a suspicion of the CP part. Bisantrene looked good though. Shares were under 10 cents and the plan was to get Bisantrene proved up and flip it for around $10 per share. Happy days. Seemed plausible so I piled in.
Then CPACS! Giddy up. But also a little niggling issue with central line being the only way to administer orange crush (110).
Can't fight all those cancers via FTO inhibition plus protect hearts if central line is the only way for Bisantrene to get in. Must invent IV formulation (220) so LT's CPACS can save lives and bring us big casino. Some massive Lederle heads tried in the past but failed. It looks like we have succeeded. Some past directors IMO didn't want to try and threw their toys out of the cot. Johnprent saw the writing on the wall years ago. This has cost us time but now we are back on track with a massive opportunity. Right now I think we are suffering from the Osborne Effect. Yeah, RC110 has value but RC220 is new and shiny and coming. To me when RC220 is up and running it will be a massive waypoint in this company's progress and in my mind derisks the Race proposition much further. Yeah, mistakes have been made and my Race plan has taken much longer than I first envisioned but I think this extra time will be well worth it. Cheers. Onward.